Tetraspanin CD9 is a "proteolipid," and its interaction with α3 integrin in microdomain is promoted by GM3 ganglioside, leading to inhibition of laminin-5-dependent cell motility

Tetraspanin CD9 is a "proteolipid," and its interaction with α3 integrin in microdomain is promoted by GM3 ganglioside, leading to inhibition of laminin-5-dependent cell motility
复制标题

DOI:
10.1074/jbc.m200771200
复制
发表时间:
2002-09-13
影响因子:
4.8
通讯作者:
Hakomori, S
Hakomori, S
中科院分区:
生物学2区
文献类型:
--
作者:
Kawakami, Y;Kawakami, K;Hakomori, S

文献摘要

被引文献

相似文献

GM 3神经节苷脂抑制各种细胞系中四跨膜蛋白CD 9促进的细胞运动性(Ono,M.,汉达,K.,Sonnino,S.,Withers,D.一、永井,H.,和Hakomori,S.(2001)Biochemistry 40,6414 -6421)。现报告如下。(i)CD 9具有可溶于氯仿/甲醇的新特性,可归类为“蛋白脂质”;(ii)CD 9和α(3)整联蛋白一起集中在ldlD/CD 9细胞的低密度糖脂富集微区(GEM)中,和α 3表达率(在+Gal条件下生长的细胞的值除以在-Gal条件下生长的细胞的值)在ldlD/CD 9细胞的GEM中高于对照ldlD/moc细胞,提示CD 9在+Gal条件下募集GEM中的α(3),其中存在GM 3。(iii)在+Gal与-Gal条件下生长的细胞的总提取物或膜组分中α(3)和CD 9的化学水平几乎相同,而在流式细胞术中通过抗体结合探测的细胞表面表达的α(3)在-Gal条件下高于+Gal条件。这些结果表明,在+Gal条件下合成的GM 3促进α(3)与CD 9的相互作用,这限制了α(3)与其抗体的结合。由GM 3促进的α(3)/CD 9相互作用的概念进一步得到了在+Gal条件下而不是-Gal条件下CD 9和α(3)的免疫共沉淀的支持,(ii)当GM 3在-Gal条件下外源地加入细胞时,CD 9和α(3)的免疫共沉淀增强,和(iii)在荧光激光扫描共聚焦显微镜中CD 9与α(3)和GM 3与CD 9的共定位图像。基于GM 3促进α(3)/CD 9相互作用和层粘连蛋白-5作为α(3)的真正配体的状态,发现ldlD/CD 9细胞的层粘连蛋白-5/α(3)依赖性运动在-Gal条件下大大增强,但在+Gal条件下强烈抑制。对于ldlD/moc细胞,在+Gal与-Gal条件下未观察到这种运动性差异。在+Gal条件下在ldlD/CD 9细胞中观察到的抑制作用在加入抗α(3)抗体后逆转,因此基于GEM中α(3)、CD 9和GM 3之间的相互作用。
GM3 ganglioside inhibits tetraspanin CD9-facilitated cell motility in various cell lines (Ono, M., Handa, K., Sonnino, S., Withers, D. A., Nagai, H., and Hakomori, S. (2001) Biochemistry 40,6414-6421). We now report the following. (i) CD9 has the novel feature of being soluble in chloroform/methanol, and classifiable as "proteolipid"; (ii) CD9 and alpha(3) integrin were concentrated together in the low-density glycolipid-enriched microdomain (GEM) of ldlD/CD9 cells, and the alpha(3) expression ratio (value for cells grown under +Gal condition divided by the value for cells grown under -Gal condition) in GEM of ldlD/CD9 cells was higher than that in control ldlD/moc cells, suggesting that CD9 recruits alpha(3) in GEM under +Gal condition, whereby GM3 is present. (iii) Chemical levels of alpha(3) and CD9 in the total extract or membrane fractions from cells grown under +Gal versus -Gal condition were nearly identical, whereas alpha(3) expressed at the cell surface, probed by antibody binding in flow cytometry, was higher under -Gal than +Gal condition. These results suggest that GM3 synthesized under +Gal condition promotes interaction of alpha(3) with CD9, which restricts alpha(3) binding to its antibody. A concept of the alpha(3)/CD9 interaction promoted by GM3 was further supported by W co-immunoprecipitation of CD9 and alpha(3) under +Gal but not -Gal condition, (ii) enhanced co-immunoprecipitation of CD9 and alpha(3) when GM3 was added exogenously to cells under -Gal condition, and (iii) the co-localization images of CD9 with alpha(3) and of GM3 with CD9 in fluorescence laser scanning confocal microscopy. Based on the promotion of alpha(3)/CD9 interaction by GM3 and the status of laminin-5 as a true ligand for alpha(3), the laminin-5/alpha(3)-dependent motility of ldlD/CD9 cells was found to be greatly enhanced under -Gal condition, but strongly inhibited under +Gal condition. Such a motility difference under +Gal versus -Gal condition was not observed for ldlD/moc cells. The inhibitory effect observed in ldlD/CD9 cells under +Gal condition was reversed upon addition of anti-alpha(3) antibody and is therefore based on interaction between alpha(3), CD9, and GM3 in GEM.